Avricore Health Inc (AVCR.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 450 | 420 | 183 | 18 | 0 |
| Accounts receivable | 8 | 338 | -687 | -80 | 4 |
| Other Working Capital | -112 | 233 | -143 | -78 | -471 |
| Other Operating Activity | 658 | -331 | 209 | -1,094 | -756 |
| Operating Cash Flow | $1,005 | $660 | $-438 | $-1,234 | $-1,223 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -181 | -1,022 | -1,193 | -105 | N/A |
| Purchase Of Investment | N/A | N/A | -10 | N/A | N/A |
| Purchase Sale Intangibles | -24 | -25 | -5 | -35 | 0 |
| Other Investing Activity | -24 | -25 | -5 | -35 | 0 |
| Investing Cash Flow | $-205 | $-1,047 | $-1,209 | $-140 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -30 | 0 | 0 | -1,000 | 940 |
| Debt Repayment | N/A | N/A | 0 | 0 | -14 |
| Common Stock Issued | N/A | 0 | 0 | 2,404 | 626 |
| Other Financing Activity | 87 | 43 | 254 | 1,681 | -40 |
| Financing Cash Flow | $57 | $43 | $254 | $3,085 | $1,512 |
| Beginning Cash Position | 277 | 621 | 2,013 | 303 | 14 |
| End Cash Position | 1,132 | 277 | 621 | 2,013 | 303 |
| Net Cash Flow | $856 | $-344 | $-1,392 | $1,710 | $289 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,005 | 660 | -438 | -1,234 | -1,223 |
| Capital Expenditure | -205 | -1,047 | -1,199 | -140 | N/A |
| Free Cash Flow | 799 | -386 | -1,636 | -1,375 | -1,223 |